Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| HCK | P08631 | Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) | Disease related genesEnzymesPotential drug targets | Indeterminate colitis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 4 | 0.53 | |||
| HPS4 | Q9NQG7 | BLOC-3 complex member HPS4 (Hermansky-Pudlak syndrome 4 protein) (Light-ear protein homolog) | Disease related genesHuman disease related genesPredicted intracellular proteins | AlbinismHermansky-Pudlak syndrome | Fusion and delivery mediationImmune mediation | 4 | 0.53 | |||
| ITB4 | P16144 | Integrin beta-4 (GP150) (CD antigen CD104) | Cancer-related genesCD markersDisease related genes | 1 | Epidermolysis bullosa | Adhesion and uptake mediationReceptor-signaling mediation | 4 | 0.53 | ||
| KCNH2 | Q12809 | Voltage-gated inwardly rectifying potassium channel KCNH2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Potassium voltage-gated channel subfamily H member 2) (Voltage-gated potassium channel subunit Kv11.1) | 6 | Angina pectorisCardiac arrhythmiaGenetic cardiac arrhythmia | Clinical-translation mediationFusion and delivery mediation | 4 | 0.53 | |||
| MDR3 | P21439 | Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3) | Disease related genesEnzymesHuman disease related genes | 12 | Intrahepatic cholestasisAcute myeloid leukaemiaBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 4 | 0.53 | ||
| PD2R | Q13258 | Prostaglandin D2 receptor (PGD receptor) (PGD2 receptor) (Prostanoid DP receptor) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | AsthmaAllergic/hypersensitivity disorderArterial occlusive disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 4 | 0.53 | ||
| AA2AR | P29274 | Adenosine receptor A2a | Cancer-related genesFDA approved drug targetsG-protein coupled receptors | 7 | Alzheimer diseaseArterial occlusive diseaseChoreiform disorder | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| AAK1 | Q2M2I8 | AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1) | EnzymesPredicted intracellular proteins | General pain disorderCOVID-19Rheumatoid arthritis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | |||
| ABCA1 | O95477 | Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) | Disease related genesEnzymesFDA approved drug targets | 15 | AtherosclerosisCoronary atherosclerosisDyslipidemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.53 | ||
| ADCY3 | O60266 | Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3) | Disease related genesEnzymesHuman disease related genes | 12 | Obesity | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 3 | 0.53 |